Table 2.
Characteristics of Patients With Breast Cancer in the Independent Sample From the Target Population* From an Integrated Health Care System Who Received Chemotherapy in 2006-2009

| Characteristic | Overall |
Age at Diagnosis (years) |
||||
|---|---|---|---|---|---|---|
| < 65 |
≥ 65 |
|||||
| No. | % | No. | % | No. | % | |
| Total | 1,575 | 100 | 1,277 | 100 | 298 | 100 |
| Age, years | ||||||
| < 54 | 779 | 49 | 779 | 61 | N/A | N/A |
| 55-64 | 498 | 32 | 498 | 39 | N/A | N/A |
| 65-74 | 250 | 16 | N/A | N/A | 250 | 84 |
| ≥ 75 | 48 | 3 | N/A | N/A | 48 | 16 |
| Race | ||||||
| Asian | 218 | 14 | 204 | 16 | 14 | 5 |
| Black | 137 | 9 | 118 | 9 | 19 | 6 |
| White | 1,075 | 68 | 826 | 65 | 249 | 84 |
| Other | 145 | 9 | 129 | 10 | 16 | 5 |
| Hispanic† | ||||||
| No | 1,369 | 87 | 1097 | 86 | 272 | 91 |
| Yes | 204 | 13 | 178 | 14 | 26 | 9 |
| AJCC6 stage‡ | ||||||
| 1 | 470 | 30 | 392 | 31 | 78 | 26 |
| 2a/2b | 771 | 49 | 620 | 49 | 151 | 51 |
| 3a/3b/3c/ | 319 | 20 | 252 | 20 | 67 | 22 |
| Anthracyclines | ||||||
| No | 476 | 30 | 340 | 27 | 136 | 46 |
| Yes | 1,099 | 70 | 937 | 73 | 162 | 54 |
| Taxanes | ||||||
| No | 530 | 34 | 404 | 32 | 126 | 42 |
| Yes | 1,045 | 66 | 873 | 68 | 172 | 58 |
| Trastuzumab | ||||||
| No | 1,251 | 79 | 1,010 | 79 | 241 | 81 |
| Yes | 324 | 21 | 267 | 21 | 57 | 19 |
Abbreviations: AJCC, American Joint Committee on Cancer; N/A, not applicable.
Study population from Kwan et al.24
Two patients with unknown ethnicity.
Fifteen patients with unknown stage.